Infectious Disease Diagnostics Market to Surpass US$ 25.7 Billion Threshold by 2026 Globally
Infectious diseases are caused by organisms such as bacteria, viruses, fungi, and parasites and are capable of transmission from one species to another species. Diagnosis of these diseases involves identifying the pathogen and its type and the degree up to which the infection has spread. Infectious diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and can be efficiently diagnosed with the help of diagnostic tests available for the respective diseases. Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular techniques, immunodiagnostics, and conventional culturing, and staining techniques. Biochemical techniques include ELISA, agglutination, and others, while molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.
Infectious diseases are caused by organisms such as bacteria, viruses, fungi, and parasites and are capable of transmission from one species to another species. Diagnosis of these diseases involves identifying the pathogen and its type and the degree up to which the infection has spread. Infectious diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and can be efficiently diagnosed with the help of diagnostic tests available for the respective diseases. Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular techniques, immunodiagnostics, and conventional culturing, and staining techniques. Biochemical techniques include ELISA, agglutination, and others, while molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostics</strong> <strong>Market</strong> -<br />
Size, Share, Outlook, and Opportunity<br />
Analysis, 2018 - <strong>2026</strong><br />
<strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostics</strong> <strong>Market</strong> <strong>by</strong> Product Type (Kits & Reagents, and<br />
Instruments), By <strong>Disease</strong> Type (HIV, Hepatitis, Healthcare Associated Infections<br />
(HAIs), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, and Others), By<br />
Technology (Immunodiagnostics, Polymerase Chain Reaction, Next Generation<br />
Sequencing, and Others), By Test Location (Labora<strong>to</strong>ry Testing, Point of Care<br />
Testing), By End User (Hospitals, Pathology/Diagnostic Labora<strong>to</strong>ries, Research<br />
Institutes, Home-Care Settings, and Others), and Region (North America, Latin<br />
America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast <strong>to</strong><br />
<strong>2026</strong><br />
<strong>Infectious</strong> diseases are caused <strong>by</strong> organisms such as bacteria, viruses, fungi, and parasites and<br />
are capable of transmission from one species <strong>to</strong> another species. Diagnosis of these diseases<br />
involves identifying the pathogen and its type and the degree up <strong>to</strong> which the infection has<br />
spread. <strong>Infectious</strong> diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent<br />
and can be efficiently diagnosed with the help of diagnostic tests available for the respective<br />
diseases. Technologies utilized <strong>by</strong> these diagnostic tests are classified in<strong>to</strong> biochemical<br />
techniques, molecular techniques, immunodiagnostics, and conventional culturing, and staining<br />
techniques. Biochemical techniques include ELISA, agglutination, and others, while molecular<br />
techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing<br />
techniques. These tests are capable of diagnosing the infectious diseases accurately with high<br />
throughput capacity.<br />
Advances in molecular testing techniques have resulted in fast diagnosis of infectious diseases in<br />
real-time due <strong>to</strong> which patients can receive treatment early. Commercially available diagnostic<br />
tests include BD Max Smart Cycler, GeneXpert, BD Phoenix CPO detect test, Xpert Xpress Strep<br />
A, and BioPlex 2200 Syphilis Total & RPR Assay. <strong>Infectious</strong> diseases such as HIV, tuberculosis, and<br />
malaria are prevalent in emerging economies such as Africa and Asia Pacific. For instance,<br />
according <strong>to</strong> the World Health Organization (WHO), an estimated 36.7 million people were<br />
suffering from HIV in 2016.<br />
Request Sample Copy of this Business Report @
https://www.coherentmarketinsights.com/insight/request-sample/1971<br />
According <strong>to</strong> the World Health Organization (WHO), in 2015, an estimated 32,000 deaths from<br />
tuberculosis and around 323,000 new cases of TB cases were registered in the Europe. Moreover,<br />
around 323,000 incident of TB cases in this region includes 27,000 cases with HIV co-infection.<br />
According <strong>to</strong> the data published in the Journal of Infection and Public Health, infectious diseases<br />
reported the significant causes of deaths in Brazil, in 2016. The high concentration of burden<br />
rates observed among men, children under 5 years of age at the coast regions of the state.<br />
According <strong>to</strong> the Centers for <strong>Disease</strong> Control and Prevention (CDC), around 5,251 deaths were<br />
reported due <strong>to</strong> influenza infection were registered in 2015. According <strong>to</strong> the National<br />
Ambula<strong>to</strong>ry Medical Care Survey: 2015 data findings, around 16.8 million people visit <strong>to</strong><br />
physician for treatment of infectious and parasitic diseases in U.S. According <strong>to</strong> the World Health<br />
Organization (WHO), 2016, around 10.4 million people were affected with tuberculosis and an<br />
estimated 1 million pediatric population was affected with tuberculosis. Increasing prevalence of<br />
diseases would propel the infectious disease diagnostics market.<br />
The New York Governor’s Office announced a research collaboration with Regeneron<br />
Pharmaceuticals, Inc. <strong>to</strong> advance the diagnosis and treatment of tick-borne diseases in June<br />
2018. Moreover, <strong>Infectious</strong> <strong>Disease</strong>s Society of America (IDSA) and American Society for<br />
Microbiology (ASM) released a guide in July 2018, which is expected <strong>to</strong> help healthcare providers<br />
<strong>to</strong> understand latest technology trends, and knowledge on when <strong>to</strong> order which test. These<br />
fac<strong>to</strong>rs are expected <strong>to</strong> affect the growth of infectious disease diagnostic market over the<br />
forecast period.<br />
Browse More About the Keyword <strong>Market</strong> Study @<br />
https://www.coherentmarketinsights.com/market-insight/infectious-disease-diagnosticsmarket-1971<br />
Report includes chapters which deeply display the following deliverable about industry:<br />
• <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostics</strong> <strong>Market</strong> Research Objective and Assumption<br />
• <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostics</strong> <strong>Market</strong> Purview - Report Description, Executive Summary, and<br />
Coherent Opportunity Map (COM)<br />
• <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostics</strong> <strong>Market</strong> Dynamics, Regulations, and Trends Analysis - <strong>Market</strong><br />
Dynamics, Regula<strong>to</strong>ry Scenario, Industry Trend, Merger and Acquisitions, New system<br />
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis<br />
• Global <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostics</strong> <strong>Market</strong>, By Regions<br />
• <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostics</strong> <strong>Market</strong> Competition <strong>by</strong> Manufacturers including Production, Share,<br />
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.<br />
• <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostics</strong> <strong>Market</strong> Manufacturers Profiles/Analysis including Company Basic<br />
Information, Manufacturing Base and Its Competi<strong>to</strong>rs.<br />
• <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostics</strong> <strong>Market</strong> Manufacturing Cost Analysis including Key Raw Materials<br />
and Key Suppliers of Raw Materials.<br />
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers<br />
• <strong>Market</strong>ing Strategy Analysis, Distribu<strong>to</strong>rs/Traders including <strong>Market</strong>ing Channel, <strong>Market</strong> Positioning<br />
and Distribu<strong>to</strong>rs/Traders List.<br />
• <strong>Market</strong> Effect Fac<strong>to</strong>rs Analysis including Technology Progress/Risk, Consumer Needs/Cus<strong>to</strong>mer<br />
Preference Change and Economic/Political Environmental Change.<br />
• <strong>Infectious</strong> <strong>Disease</strong> <strong>Diagnostics</strong> <strong>Market</strong> Forecast including Production, Consumption, Import and<br />
Export Forecast <strong>by</strong> Type, Applications and Region.<br />
• Research Findings and Conclusion<br />
Table of Contents of Keyword <strong>Market</strong> Report:<br />
1. Research Objective and assumption<br />
2. <strong>Market</strong> Purview<br />
3. <strong>Market</strong> Dynamics, Regulations, and Trends Analysis<br />
4. Keyword <strong>Market</strong>, By Advanced Water Meters, 2017 - 2025 (USD Million)<br />
5. Keyword <strong>Market</strong>, By Service, 2017 - 2025 (USD Million)<br />
6. Keyword <strong>Market</strong>, By Solution, 2017 - 2025 (USD Million)<br />
7. Keyword <strong>Market</strong>, By Regions, 2017 - 2025 (USD Million)<br />
8. Competitive Landscape<br />
Ask for Discount before Buying @<br />
https://www.coherentmarketinsights.com/insight/request-discount/1971<br />
About Coherent <strong>Market</strong> Insights:<br />
Coherent <strong>Market</strong> Insights is a prominent market research and consulting firm offering action-ready<br />
syndicated research reports, cus<strong>to</strong>m market analysis, consulting services, and competitive analysis<br />
through various recommendations related <strong>to</strong> emerging market trends, technologies, and potential<br />
absolute dollar opportunity.<br />
Contact Us:<br />
Mr. Shah<br />
Coherent <strong>Market</strong> Insights<br />
1001 4th Ave,<br />
#3200<br />
Seattle, WA 98154<br />
Tel: +1-206-701-6702<br />
Email: sales@coherentmarketinsights.com
Change language